B
Barbara A. Goff
Researcher at University of Washington
Publications - 235
Citations - 12862
Barbara A. Goff is an academic researcher from University of Washington. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 61, co-authored 227 publications receiving 11859 citations. Previous affiliations of Barbara A. Goff include Georgetown University & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
John B. Liao,William R. Gwin,Renata R. Urban,Katie M. Hitchcock-Bernhardt,Andrew L. Coveler,Doreen Higgins,Jennifer Childs,Hania Shakalia,Ron E. Swensen,Sasha E. Stanton,Anna V. Tinker,Tanya A. Wahl,Richard G Ancheta,Kathryn F. McGonigle,James Y. Dai,Mary L. Disis,Barbara A. Goff +16 more
TL;DR: In this paper, the authors evaluated activity and safety of pembrolizumab with carboplatin in recurrent platinum-resistant ovarian cancer and showed that the combination was well-tolerant and active in recurrent ovarian cancer.
Journal ArticleDOI
An updated safety analysis of OCEANS, a randomized, double-blind, phase III trial of gemcitabine (G) and carboplatin (C) with bevacizumab (BV) or placebo (PL) followed by BV or PL to disease progression (PD) in patients with platinum-sensitive (Plat-S) recurrent ovarian cancer.
Carol Aghajanian,Stephanie V. Blank,Barbara A. Goff,Patricia L. Judson,Lawrence R. Nycum,Mika A. Sovak,Jing Yi,Amreen Husain +7 more
TL;DR: OCEANS met its primary end point with a statistically significant and clinically meaningful hazard ratio for progression-free survival (PFS) of 0.484 as mentioned in this paper, including objective response rate, overall survival, and safety.
Journal ArticleDOI
Evaluation of a Validated Biomarker Test in Combination With a Symptom Index to Predict Ovarian Malignancy.
TL;DR: The addition of a patient-reported SI, which captures subjective symptoms in an objective manner, improved the sensitivity of MIA across all stages and subtypes of ovarian cancer.
Journal ArticleDOI
A Randomized Multicenter Study Assessing the Educational Impact of a Computerized Interactive Hysterectomy Trainer on Gynecology Residents.
A.S. Lichtman,William Parker,Barbara A. Goff,Neeraj Mehra,Eliane M. Shore,Guylaine Lefebvre,Alexander Chiang,John P. Lenihan,Henk W.R. Schreuder +8 more
TL;DR: Using the Laparoscopic Hysterectomy Trainer significantly increased knowledge of the hystereCTomy procedure in PGY 1 and 2 gynecology residents.